Christelle Graizeau
Research Subjects
Research Interests
Christelle Graizeau has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Helena Polena
NAOS (Bioderma), 13290 Aix-en-Provence, France
2 shared publications Michèle Sayag
Research and Development Department NAOS Ecobiology Company (Bioderma) Aix‐en‐Provence France
2 shared publications- Benoît Cadars
NAOS Ecobiology Company (Bioderma) Aix‐en‐Provence France
1 shared publication Catherine Queille‐Roussel
Center of Clinical Pharmacology Applied to Dermatology (CPCAD) L'Archet 2 Hospital Nice France
1 shared publication- Elodie Prestat‐Marquis
NAOS Ecobiology Company (Bioderma) Aix‐en‐Provence France
1 shared publication Ewa Chlebus
Niepubliczny Zakład Opieki Zdrowotnej, NovaDerm Warszaw Poland
1 shared publication
Latest Publications
- Open Access
- 27 September 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (10) , e70450
Comparison of Visible Light‐Protective Tinted Sunscreen to Untinted Sunscreen to Protect Melasma Patients During Summer: A Prospective Randomized Investigator‐Blinded Study
- 27 September 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (10) , e70450
Open AccessComparison of Visible Light‐Protective Tinted Sunscreen to Untinted Sunscreen to Protect Melasma Patients During Summer: A Prospective Randomized Investigator‐Blinded Study
- Open Access
- 19 August 2025
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 48 (1) , 70-82
Evaluation of the sensitive skin syndrome and the effect of a dermo‐cosmetic treatment in Thai and Polish subjects
Objective: Sensitive skin syndrome (SSS) affects individuals from all ethnic groups. However, studies across different populations remain limited, despite recognised differences between populations. Thus, we examined SSS in Thai and Polish subjects, assessing the tolerance and efficacy of a dermo‐cosmetic product in both populations. Methods: Thai participants were involved in a 28‐day open‐label study, while Polish subjects took part in a 56‐day double‐blind, randomised study comparing the product with a control cream. Clinical and functional signs were evaluated, alongside quality of life (QoL) using the Burden of Sensitive Skin (BoSS) questionnaire. Results: The product was well tolerated in both groups over time, leading to significant improvements in all clinical and functional signs ( p < 0.05 to p < 0.001) and enhancing QoL ( p < 0.005 in Thailand; p < 0.001 in Poland). At baseline, Polish subjects exhibited greater redness and higher BoSS scores to questions relating to visual signs ( p < 0.001). Conversely, Thai participants reported more pronounced tingling, pain and itching, along with higher BoSS scores relating to sensory symptoms ( p < 0.001). Conclusions: The study highlights differences existing in the perception of SSS symptoms between a Thai and Polish population and demonstrates that the dermo‐cosmetic cream effectively alleviates SSS symptoms and improves QoL in both ethnic groups.
- 19 August 2025
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 48 (1) , 70-82
Open AccessEvaluation of the sensitive skin syndrome and the effect of a dermo‐cosmetic treatment in Thai and Polish subjects
Objective: Sensitive skin syndrome (SSS) affects individuals from all ethnic groups. However, studies across different populations remain limited, despite recognised differences between populations. Thus, we examined SSS in Thai and Polish subjects, assessing the tolerance and efficacy of a dermo‐cosmetic product in both populations. Methods: Thai participants were involved in a 28‐day open‐label study, while Polish subjects took part in a 56‐day double‐blind, randomised study comparing the product with a control cream. Clinical and functional signs were evaluated, alongside quality of life (QoL) using the Burden of Sensitive Skin (BoSS) questionnaire. Results: The product was well tolerated in both groups over time, leading to significant improvements in all clinical and functional signs ( p < 0.05 to p < 0.001) and enhancing QoL ( p < 0.005 in Thailand; p < 0.001 in Poland). At baseline, Polish subjects exhibited greater redness and higher BoSS scores to questions relating to visual signs ( p < 0.001). Conversely, Thai participants reported more pronounced tingling, pain and itching, along with higher BoSS scores relating to sensory symptoms ( p < 0.001). Conclusions: The study highlights differences existing in the perception of SSS symptoms between a Thai and Polish population and demonstrates that the dermo‐cosmetic cream effectively alleviates SSS symptoms and improves QoL in both ethnic groups.